236
Participants
Start Date
February 24, 2011
Primary Completion Date
November 1, 2019
Study Completion Date
April 21, 2020
High-dose colesevelam
3.75 grams colesevelam hydrochloride in oral suspension
Low-dose colesevelam
0.625 grams colesevelam hydrochloride in oral suspension
New York
Philadelphia
Baltimore
Raleigh
Greenville
Atlanta
Tampa
Nashville
Cincinnati
Chicago
Kansas City
Little Rock
Oklahoma City
Oklahoma City
Dallas
Houston
San Antonio
Aurora
Tucson
Los Angeles
San Diego
Oakland
Hartford
Springfield
Lead Sponsor
Daiichi Sankyo
INDUSTRY